ライフサイエンスコーパス: infant formula

1 ted formula, and an unopened can of powdered infant formula.

2 n recovered from an unopened can of powdered infant formula.

3 milk, and 4744 (31%) were only or mostly fed infant formula.

4 was applied to the digestion of a commercial infant formula.

5 well absorbed from breast milk compared with infant formula.

6 ally important in infants fed iron-fortified infant formula.

7 high, whereas it is lower from cow milk and infant formula.

8 the quantification of soymilk in adulterated infant formula.

9 ion (GID) of six sterilised model systems of infant formula.

10 of lactose-free foods including lactose-free infant formula.

11 re infant death, and the costs of purchasing infant formula.

12 below the FDA's tolerance level of 1 ppm in infant formula.

13 ul tool to help with development of improved infant formulas.

14 eeds to be considered in the modification of infant formulas.

15 o that of lactose-containing, cow-milk-based infant formulas.

16 hts the issues related to the composition of infant formulas.

17 dd long-chain polyunsaturated fatty acids to infant formulas.

18 h other carbohydrate sources for specialized infant formulas.

19 l of lactoferrin, perhaps as a supplement in infant formulas.

20 ir glucoside conjugates in various soy-based infant formulas.

21 human or bovine milk or bovine milk-derived infant formulas.

22 which is desired in heart-healthy foods and infant formulas.

23 mixtures of ascorbic acid and in commercial infant formulas.

24 proximately 3- to 4-fold above the untreated infant formulas.

25 bules and processed submicronic emulsions in infant formulas.

26 ssary for newborn growth in maternal milk or infant formulas.

27 are an interesting alternative to cow's milk infant formulas.

28 be used to design the optimal composition of infant formulas.

29 pplied to determine melamine in cow milk and infant formulas.

30 randomly assigned to receive iron-fortified infant formula (465 mg Ca and 317 mg P/L) or the same fo

31 ed to receive iron-fortified, cow milk-based infant formula (465 mg Ca and 317 mg P/L) or the same fo

32 include a full breastfeeding package with no infant formula, a partial breastfeeding package with som

33 llion to $2416.5 million, where the costs of infant formula accounted for 11-38% of total costs.

34 er calcium and phosphorus supplementation of infant formula affects the iron status of healthy full-t

35 8.2 to 9.2 log10 CFU; the placebo was dilute infant formula alone.

36 Infant formulas also contained choline and choline-conta

37 changes in WIC food-package assignments and infant formula amounts but no change in breastfeeding in

38 outcomes: WIC food-package assignments, WIC infant formula amounts, and breastfeeding initiation.

39 y for the analysis of vitamin B9 (folate) in infant formula and adult/pediatric nutritional products

40 rmula containing either lactose or CSS-based infant formula and compared with an equal number of excl

41 as observed between the use of ready to feed infant formula and enamel fluorosis.

42 d in the bioaccessible (soluble) fraction of infant formula and human milk are employed.

43 rapid and robust method for the analysis of infant formula and infant liquid milk samples.

44 on of <0.5 mug mL(-1) was determined in both infant formula and infant liquid milk.

45 Infant formula and orange juice samples were analyzed wi

46 e may be used for routine quality control of infant formula and other food ingredients containing pre

47 ree choline moiety is adequately provided by infant formulas and bovine milk, reevaluation of the con

48 After changing to hydrolyzed infant formulas and breast milk ahead of dairy products

49 change from cow' milk formula to hydrolyzed infant formulas and breast milk ahead of dairy products

50 Current selenium contents of infant formulas and recommendations for dietary intakes

51 Use of soy-based infant formulas and soy/isoflavone supplements has arous

52 inc and copper absorption from several human infant formulas and the effect of phytate concentration

53 lly available 5'-mononucleotide supplemented infant formulas and three human breast milk samples were

54 a, a partial breastfeeding package with some infant formula, and a full formula package with a smalle

55 an additive in baked goods, dairy products, infant formula, and dietary supplements as a result of i

56 nistein and daidzein, two isoflavones in soy infant formula, and existing human studies of soy formul

57 on of MEL in different raw milk and powdered infant formula, and satisfactory results were obtained (

58 Infant formulas are designed specifically to mimic the c

59 Modifications to infant formulas are made when the preponderance of scien

60 Soy infant formulas are widely used, but few studies have ev

61 DHA supplementation of infant formula at 0.32% of total fatty acids improves vi

62 flavones and soyasaponins in seven soy-based infant formulas available in the Brazilian market to est

63 e support for addition of LCPUFA to standard infant formula but we are now doing further follow-up of

64 ciation and as a rationale for adding DHA to infant formula, but few long-term data support this poss

65 ated the level of H2O2 generated in the same infant formulas by approximately 3- to 4-fold above the

66 ured the absorption of calcium and zinc from infant formulas by using a multitracer, stable-isotope t

67 /kg), a constituent of human breast milk and infant formulas, by gavage, and plasma samples and brain

68 d use of essential fatty acid derivatives in infant formula can certainly be questioned on the basis

69 ifications occurring during sterilisation of infant formulas can affect protein digestibility and rel

70 Selenate fortification of infant formulas can improve the selenium status of prete

71 these differences highlight that changes in infant formula composition impact infant metabolism, and

72 The infant formulas contained ascorbate radicals ranging fro

73 All infant formulas contained significantly less phosphochol

74 non-selenium-fortified preterm and full-term infant formulas containing 0.12 and 0.11 mumol Se/L, res

75 ved selenate-fortified preterm and full-term infant formulas containing 0.36 and 0.22 mumol Se/L, res

76 omly assigned to be fed 1 of the following 4 infant formulas containing equivalent nutrient amounts,

77 chidonic acid (ARA) in human milk but not in infant formula, coupled with lower plasma and brain lipi

78 Three commercial infant formulas (denoted as P1, P2 and P3) were stored a

79 In infant formulas derived from soy or bovine milk, unester

80 uman breast milk are important indicators of infant formula DHA and AA concentrations, and recent evi

81 aining HAAs) for the preparation of powdered infant formula did not remove them; therefore it would b

82 endations for the mineral content of preterm infant formula differ greatly between committees.

83 trointestinal digestion system, for studying infant formula digestion, and to validate it by comparin

84 Understanding the mechanisms of infant formula disintegration in the infant gastrointest

85 This diet, ADM, contains milk protein, and infant formula, dissolved in a mixture of bovine red blo

86 LCP supplementation of term infant formula during the first year of life yields clea

87 idative properties of structured lipid-based infant formula emulsion containing dairy proteins, lacto

88 ssful incorporation of structured lipid into infant formula emulsion for better infant nutrition and

89 menhaden fish oil and structured lipid-based infant formula emulsion, were evaluated and compared.

90 Nowadays, a great number of infant formulas enriched with prebiotics are disposal in

91 its intended purpose in the highly regulated infant formula environment, including liquid formulation

92 More than 80% of the infant formulas examined had ratios of iron to copper ex

93 Soy-based infant formula feeding and ultrasound-detected uterine f

94 er allowable limit of the protein content of infant formulas for the first year of life and limiting

95 ree nationally prominent commercial powdered infant formulas generated hydrogen peroxide, ranging fro

96 breve BBG-001 suspended in dilute elemental infant formula given enterally in a daily dose of 8.2 to

97 ypothesis that nucleotide supplementation of infant formula has beneficial effects on fecal bacteriol

98 The chemical composition of infant formulas has been optimized but not the structure

99 a common contaminant of milk-based powdered infant formula, has been implicated as a causative agent

100 f e-beam on chemical changes of nutrients in infant formula have not been determined.

101 ve antiretroviral prophylaxis, and access to infant formula have resulted in new perinatal infections

102 Soy-based infant formulas have been in use for >30 y.

103 ation of carbohydrates present in commercial infant formulas have been used.

104 Recent modifications in the fat blend of infant formulas have led to improved fat digestibility.

105 y-processed emulsion and two processed model infant formulas (homogenized or homogenized/pasteurized)

106 PLC-DAD in 20 commercial milk-based powdered infant formula (IF) brands from local markets from Paris

107 eurized, and lactose-free UHT milk (ULF) and infant formula (IF) using tandem mass spectrometry (elec

108 pid oxidation of structured lipid (SL)-based infant formula (IF) was evaluated.

109 sphatidylinositol (PI) species present in 32 infant formulas (IF) collected from Australia, Europe an

110 tra high temperature (UHT) treated milk, and infant formulas (IFs) after digesting the precipitated p

111 Since breastfeeding is not always possible, infant formulas (IFs) are supplemented with prebiotic ol

112 fect of calcium- and phosphorus-supplemented infant formula in preventing lead absorption.

113 tween fluorosis on these enamel surfaces and infant formula in the form of powdered concentrate (OR=4

114 Thus, the use of soy-based infant formulas in the absence of medical necessity and

115 e will be more bioactive components added to infant formulas in the near future, but guidelines on ho

116 The vast majority of infant formulas in the United States contain the long-ch

117 rted interacting with the pharmaceutical and infant formula industries.

118 ally fluoridated children, born after the US infant formula industry voluntarily reduced the fluoride

119 A or DHA when they are fed in combination as infant formula ingredients.

120 metabolic fate of isoflavones from soy-based infant formula is described.

121 ility of adding their bovine counterparts to infant formula is discussed as well as the implications

122 The appropriate amount of protein to use in infant formula is still under discussion.

123 sideration when adding bioactive proteins to infant formula is that the total protein content of form

124 The choice of infant formula is thought to play an important role on g

125 Absorption of calcium from a lactose-free infant formula is, however, adequate to meet the calcium

126 The required amount of iodine in infant formulas is based on caloric content, and the lab

127 re for the determination of iron and zinc in infant formulas is presented.

128 quantitative significance of this effect in infant formulas is uncertain.

129 ly exposure of infants to isoflavones in soy infant-formulas is 6-11 fold higher on a bodyweight basi

130 sual measures used to assess the efficacy of infant formula LCPUFA supplementation are the electroret

131 s at age 4 mo in infants fed a lower-protein infant formula (LPF) or a lower-protein infant formula w

132 If so, varying the constituents of infant formula might be therapeutically advantageous.

133 hain polyunsaturated fatty acids (LCPUFA) to infant-formula milk during the first 6 months promotes l

134 -month-old infants fed exclusively soy-based infant formula (n = 7), cow-milk formula (n = 7), or hum

135 MFGM supplementation to infant formula narrows the gap in cognitive development

136 effects of mineral concentrations in preterm infant formula on bone mineralization are lacking, recom

137 ied corn and rice starches (MCS, MRS)) to an infant formula on both in vitro mineral availability (Ca

138 The impact of probiotic-supplemented infant formula on the composition and function of the in

139 of nutritional intervention with hydrolysate infant formulas on allergic manifestations in high-risk

140 ght to investigate the effect of hydrolysate infant formulas on allergic phenotypes in children with

141 to take a comprehensive picture of powdered infant formulas on sale in Italy on the basis of their l

142 llent models in which to study the effect of infant formulas on trace element absorption and status.

143 infants either via drops or as contained in infant formula or foods.

144 sodium consumed comes from foods other than infant formula or human milk after the age of 6 mo.

145 Timing of introduction of solid foods, infant formula, or cow's milk was not related to risk of

146 Infants who were fed breast milk more than infant formula, or who were breastfed for longer periods

147 Three different infant formulas (P1, P2 and P3) were characterised, and

148 The "Follow-on formula" and "Infant formula" products contained the lowest average co

149 However, most of the infant formulas provide a methionine intake of 49-80 mg

150 e tested whether the reduction of protein in infant formula reduces body mass index (BMI; in kg/m(2))

151 the stereoisomeric structure of palmitate in infant formula resulted in higher WBBMC, reduced stool s

152 The low sn-2 palmitate content of infant formulas results in formation of fatty acid calci

153 PE-formula compared with that of a standard infant formula (S-formula) on arginine kinetics in criti

154 s of melamine (MEL) in raw milk and powdered infant formula samples by high performance liquid chroma

155 Soybean-based infant formulas (SBIFs) based on soybean protein isolate

156 ihypertensive peptides in five soybean-based infant formulas (SBIFs).

157 Commercially available infant formulas serve as the best alternative to human m

158 erimental designs to the question of whether infant formula should be supplemented with DHA.

159 esent recommendation that the composition of infant formulas should be based on the composition of hu

160 Lowering the protein content of infant formula so it is closer to that of mature breast

161 occasions during infancy as part of several infant formula studies, were contacted at age 20 to 32 y

162 of long-chain polyunsaturated fatty acids in infant formulas, the duration of exclusive breast-feedin

163 on (FDA) regulates the addition of iodine to infant formulas, the iodization of salt, and the additio

164 The appropriate concentration of iron in infant formula to achieve iron sufficiency is more contr

165 ormula effects could lead to modification of infant formula to improve immune function, reduce inflam

166 actooligosaccharides (GOS) that are added to infant formula to mimic the molecular sizes and prebioti

167 the ability of AA- and DHA(AA/DHA)-enriched infant formula to modulate immune responses in the neona

168 ide supplements, fluoride toothpaste, and/or infant formula use in nonfluoridated communities.

169 (FRI classification II) enamel surfaces and infant formula use in the form of powdered concentrate (

170 ing, including probiotic supplementation and infant formula use, were monitored from birth using ques

171 method to determine the melamine in milk and infant formulas using 3-amino-5-mercapto-1,2,4-triazole

172 ingredients, its final concentration in the infant formula was insufficient to decrease in vitro min

173 Infant formula was not found to be associated with fluor

174 on of fresh milk products and cow milk-based infant formulas was related to the endpoint, whereas no

175 m the infant and from an opened container of infant formula were indistinguishable, while the PFGE pr

176 r brands of commercially available soy-based infant formulas were analysed, and the plasma concentrat

177 in water and 100 parts per billion (ppb) in infant formula, which are well below the FDA's tolerance

178 Infant formula with a lower protein content reduces BMI

179 Whey-predominant infant formula with a lower protein content that more cl

180 tein infant formula (LPF) or a lower-protein infant formula with additional active ingredients (probi

181 The contamination of Chinese infant formula with melamine caused urolithiasis and oth

182 e was to test the hypothesis that feeding an infant formula with reduced energy and protein densities

183 e showed that a partially hydrolyzed protein infant formula with specific prebiotics modulated the gu

184 Treating infant formulas with the chelating agent diethylene tria

185 determine whether selenate fortification of infant formula would improve the selenium status of rela

186 erences in the composition of human milk and infant formula yield benefits in cognitive development a